These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

47 related articles for article (PubMed ID: 11601040)

  • 1. [Multivariate analysis of clinical factors in restenosis after coronary interventional treatment].
    Wen S; Mao J; Guo L
    Zhonghua Yi Xue Za Zhi; 1999 Mar; 79(3):197-9. PubMed ID: 11601040
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A single center investigation of bare-metal or drug-eluting stent restenosis from 1633 consecutive Chinese Han ethnic patients.
    Xu B; Li JJ; Yang YJ; Ma WH; Chen JL; Qiao SB; Qin XW; Yao M; Liu HB; Wu YJ; Yuan JQ; Chen J; You SJ; Dai J; Xia R; Gao RL
    Chin Med J (Engl); 2006 Apr; 119(7):533-8. PubMed ID: 16620692
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Risk factors for later restenosis after successful coronary angioplasty: Mitsui Memorial Hospital experience].
    Tohma M; Yamaguchi T
    J Cardiol; 1991; 21(1):43-52. PubMed ID: 1817180
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stenting alone versus debulking and debulking plus stent in branch ostial lesions of native coronary arteries.
    Chung CM; Nakamura S; Tanaka K; Tanigawa J; Kitano K; Akiyama T; Matoba Y; Katoh O
    Heart Vessels; 2004 Sep; 19(5):213-20. PubMed ID: 15372295
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factors predictive of cardiac events and restenosis after sirolimus-eluting stent implantation in small coronary arteries.
    Lee CW; Suh J; Lee SW; Park DW; Lee SH; Kim YH; Hong MK; Kim JJ; Park SW; Park SJ
    Catheter Cardiovasc Interv; 2007 May; 69(6):821-5. PubMed ID: 17191211
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current PTCA practice and clinical outcomes in The Netherlands: the real world in the pre-drug-eluting stent era.
    Agema WR; Monraats PS; Zwinderman AH; De Winter RJ; Tio RA; Doevendans PA; Waltenberger J; De Maat MP; Frants RR; Atsma DE; Van Der Laarse A; Van Der Wall EE; Jukema JW
    Eur Heart J; 2004 Jul; 25(13):1163-70. PubMed ID: 15231375
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insulin resistance as a predictor for restenosis after coronary stenting.
    Nishio K; Fukui T; Tsunoda F; Kawamura K; Itoh S; Konno N; Ozawa K; Katagiri T
    Int J Cardiol; 2005 Aug; 103(2):128-34. PubMed ID: 16080969
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Lesion-related factors associated with restenosis after percutaneous transluminal coronary angioplasty in the absence of patient-related factors].
    Sakai Y; Tomobuchi Y; Hashizume T; Imanishi T; Tomimoto S; Toyoda Y; Arita M; Hano T; Nishio I
    J Cardiol; 1997 Jan; 29(1):1-6. PubMed ID: 9023673
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety of sirolimus-eluting stenting and its effect on restenosis in patients with unstable angina pectoris (a SIRIUS substudy).
    Weisz G; Moses JW; Teirstein PS; Holmes DR; Raizner AE; Satler LF; Mishkel G; Wilensky RL; Wang P; Kuntz RE; Popma JJ; Leon MB
    Am J Cardiol; 2007 Apr; 99(8):1044-50. PubMed ID: 17437725
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Pulse pressure as a predictor of restenosis after percutaneous transluminal coronary angioplasty].
    Jankowski P; Kawecka-Jaszcz K; Bryniarski L; Czarnecka D; Zabojszcz M; Styczkiewicz M
    Przegl Lek; 2001; 58(12):1025-8. PubMed ID: 12041014
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The importance of serum lipid level for restenosis following initial successful percutaneous transluminal coronary angioplasty in patients with unstable angina].
    Kishi K; Hiasa Y; Tanaka H; Tanimoto M; Kinoshita M; Shinohara A; Wada T; Aihara T
    J Cardiol; 1996 Aug; 28(2):79-84. PubMed ID: 8814525
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recruitable collateral blood flow index predicts coronary instent restenosis after percutaneous coronary intervention.
    Jensen LO; Thayssen P; Lassen JF; Hansen HS; Kelbaek H; Junker A; Pedersen KE; Hansen KN; Krusell LR; Botker HE; Thuesen L
    Eur Heart J; 2007 Aug; 28(15):1820-6. PubMed ID: 17456484
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mean platelet volume as marker of restenosis after percutaneous transluminal coronary angioplasty in patients with stable and unstable angina pectoris.
    Yang A; Pizzulli L; Lüderitz B
    Thromb Res; 2006; 117(4):371-7. PubMed ID: 15935453
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Usefulness of preprocedural soluble CD40 ligand for predicting restenosis after percutaneous coronary intervention in patients with stable coronary artery disease.
    Türker S; Güneri S; Akdeniz B; Ozcan MA; Baris N; Badak O; Kirimli O; Yüksel F
    Am J Cardiol; 2006 Jan; 97(2):198-202. PubMed ID: 16442363
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute coronary syndrome may occur with in-stent restenosis and is associated with adverse outcomes (the PRESTO trial).
    Assali AR; Moustapha A; Sdringola S; Denktas AE; Willerson JT; Holmes DR; Smalling RW
    Am J Cardiol; 2006 Sep; 98(6):729-33. PubMed ID: 16950172
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevated whole-blood tissue factor procoagulant activity as a marker of restenosis after percutaneous transluminal coronary angioplasty and stent implantation.
    Tutar E; Ozcan M; Kilickap M; Gülec S; Aras O; Pamir G; Oral D; Dandelet L; Key NS
    Circulation; 2003 Sep; 108(13):1581-4. PubMed ID: 12975255
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Usefulness of serum N-terminal pro-brain natriuretic peptide to predict in-stent restenosis in patients with preserved left ventricular function and normal troponin I levels.
    Hong SN; Ahn Y; Yoon NS; Lee KH; Kim YS; Hwang SH; Lee SR; Kim KH; Park HW; Hong YJ; Kim JH; Jeong MH; Cho JG; Park JC; Kang JC
    Am J Cardiol; 2007 Apr; 99(8):1051-4. PubMed ID: 17437726
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elective stenting in small coronary arteries: results of the Italian prospective multicenter registry MICROSCOPE.
    Airoldi F; Di Mario C; Presbitero P; Maiello L; Carcagnì A; Bortone A; Cremonesi A; Castriota F; Frasheri A; Rubino A; Pernice V; Rubartelli P; Reimers B; Colombo A
    Ital Heart J; 2002 Jul; 3(7):406-11. PubMed ID: 12189969
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Restenosis after percutaneous transluminal coronary angioplasty in patients with non-insulin-dependent diabetes mellitus (NIDDM).
    Asakura Y; Suzuki M; Nonogi H; Haze K; Sato A; Inada H; Okuda Y; Yamashita K; Harano Y
    J Cardiovasc Risk; 1998; 5(5-6):331-4. PubMed ID: 9920005
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multiple predictors of coronary restenosis after drug-eluting stent implantation in patients with diabetes.
    Hong SJ; Kim MH; Ahn TH; Ahn YK; Bae JH; Shim WJ; Ro YM; Lim DS
    Heart; 2006 Aug; 92(8):1119-24. PubMed ID: 16449516
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.